For the quarter ending 2026-03-31, SLGN had -$645,230K decrease in cash & cash equivalents over the period. -$882,017K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Stock compensation expense | - | - | 5,161 | 7,755 |
| Net income | 63,039 | 18,204 | 113,293 | 156,906 |
| Depreciation and amortization | 84,932 | 80,953 | 82,875 | 155,335 |
| Amortization of debt discount and debt issuance costs | 1,634 | 1,622 | 1,294 | 2,617 |
| Rationalization charges | 9,047 | 32,497 | 7,189 | 20,823 |
| Stock compensation expense | 5,699 | 18,020 | - | - |
| Loss on early extinguishment of debt | -1,017 | 0 | - | - |
| Deferred income tax provision (benefit) | - | 19,278 | - | - |
| Trade accounts receivable, net | 575,596 | -911,671 | 259,361 | 601,838 |
| Inventories | 54,023 | 58,650 | -236,377 | 293,758 |
| Trade accounts payable | -313,941 | 279,914 | 96,608 | -279,697 |
| Accrued liabilities | -17,839 | 35,370 | 18,416 | -19,577 |
| Other, net | 3,542 | 32,157 | -39,034 | 53,417 |
| Net cash (used in) operating activities | -799,573 | 1,293,806 | 340,886 | -904,851 |
| Purchase of business, net of cash acquired | - | 0 | - | - |
| Capital expenditures | 82,444 | 71,301 | 80,098 | 155,693 |
| Proceeds from asset sales | 2,067 | 284 | 204 | 9,552 |
| Other, net | -396 | -1,040 | 1,590 | -297 |
| Net cash (used in) investing activities | -79,981 | -69,977 | -81,484 | -145,844 |
| Borrowings under revolving loans | 1,069,325 | 19,569 | 82,326 | 1,409,738 |
| Repayments under revolving loans | 162,528 | 599,553 | 883,873 | 51,959 |
| Repayment of principal amounts underfinanceleases | 1,181 | 944 | 1,543 | 2,427 |
| Proceeds from issuance of long-term debt | - | 0 | 703,620 | - |
| Repayments of long-term debt | 542,500 | 18,922 | 0 | 706,274 |
| Changes in outstanding checks - principally vendors | -97,369 | 97,369 | 0 | -84,971 |
| Dividends paid on common stock | 22,849 | 20,998 | 21,411 | 43,362 |
| Debt issuance costs | 1,260 | 681 | 8,299 | - |
| Repurchase of common stock | 7,844 | 8,744 | 59,287 | 6,873 |
| Net cash provided by financing activities | 233,794 | -532,904 | -188,467 | 513,872 |
| Effect of exchange rate changes on cash and cash equivalents | 530 | 564 | 773 | 31,431 |
| Net (decrease) | -645,230 | 691,489 | 71,708 | -505,392 |
| Balance at beginning of year | 1,080,659 | 389,170 | 822,854 | - |
| Balance at end of period | 435,429 | 1,080,659 | 389,170 | - |